The OHSA may be legally denied or withdrawn to a patient who is unable to act in the best of the child in cases where the request for education or training is in effect. The health team should always introduce treatments for the general use of the child and consider removing them if they are no longer useful. All curable causes of the child`s condition should be excluded, for example drugs, metabolic encephalopathy. Children`s ability to cope with compromising messages and their ability to make decisions should continue to be assessed through appropriate research. More emphasis needs to be placed on the means of communication that integrate relevant development-related technologies. This can be particularly important in ensuring that the voices of people with disabilities and their caregivers are part of ongoing treatment dialogues. More and more children with life-limiting diseases will live beyond the age of 16 or 18. Transitional provisions should be in line with good practice and subject to age-appropriate or age-appropriate legislation. Limiting treatment decisions should be consistent with ethical and legal age guidelines. All clinical staff should have access to continuing professional training and communication skills, ethics and issues raised by decisions to limit treatment. The process should be reviewed to ensure that the physical and emotional needs of children and their families facing such decisions are met.
All health care professionals have a legal duty of care to their patients and are required to act within the law. The law articulates standards of behaviour by prohibiting certain acts and authorizing others. Any practice or treatment given with the primary intent to cause death is illegal.20 Before requests for care, second medical advice and ethics advice diminish, may be helpful. Where possible, parents should be able to find another provider who is ready and able to provide treatment. Patients and Methods: In this prospective qualitative study, 76 patients with incurable cancer were included and discussed the limitation of life-prolonging treatment.